AZD-3839

DB12368InvestigationalSmall molecule

AZD3839 has been used in trials studying the basic science of Safety, Tolerability, Alzheimer's Disease, and Blood Concentration.

Chemical structure of AZD-3839
Mechanism
Curator reviewed
Formula / weight
C24H16F3N5 · 431.422 g/mol (avg)
Code names
AZD3839

Resolves to

Compound
UNIII8ID590133CAS1227163-84-9ChEMBLCHEMBL2177913PubChem46202416
Structure
InChIKeyMRXBCEQZNKUUIP-DEOSSOPVSA-NSMILESNC1=N[C@@](C2=CC=CC(F)=C12)(C1=CC=CC(=C1)C1=CN=CN=C1)C1=CC=NC(=C1)C(F)F
Targets
P56817BACE1

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with AZD-3839, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In